Finland vs Spain: Reported rate of new cervical cancer cases
Finland
5.28 per 100,000 women
in 2022
Spain
5.54 per 100,000 women
in 2016
Finland rank
36th
Spain rank
34th
Reported rate of new cervical cancer cases over time
- Finland
- Spain
How they compare
Spain currently reports 5.54 per 100,000 women against 5.28 per 100,000 women in Finland, a difference of 0.26 per 100,000 women.
Across all 24 years both countries report, Spain has been ahead every year.
Finland ranks 36th and Spain ranks 34th of 46 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Finland | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.14 per 100,000 women | 6.72 per 100,000 women | 2.58 per 100,000 women | Spain |
| 2000s | 4.03 per 100,000 women | 6.2 per 100,000 women | 2.17 per 100,000 women | Spain |
| 2010s | 4.46 per 100,000 women | 5.6 per 100,000 women | 1.14 per 100,000 women | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Finland or Spain?
- Spain, at 5.54 per 100,000 women against 5.28 per 100,000 women in Finland as of 2016.
- What is the difference in reported rate of new cervical cancer cases between Finland and Spain?
- 0.26 per 100,000 women, with Spain ahead.
- How many years of comparable data are there for Finland and Spain?
- 24 years are reported by both, from 1993 to 2016.
- How do Finland and Spain rank globally for reported rate of new cervical cancer cases?
- Finland ranks 36th and Spain ranks 34th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.